A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2019
Price : $35 *
At a glance
- Drugs PTC 596 (Primary)
- Indications Glioma
- Focus Adverse reactions; Pharmacokinetics
- 28 Feb 2019 According to a PTC Therapeutics media release, this study is expected to fully enroll by the end of 2019.
- 31 Aug 2018 Status changed from not yet recruiting to recruiting.
- 20 Jul 2018 Status changed from planning to not yet recruiting.